Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20241007063280N1Phase 3Completed
Phase 3, open-label trial of lidocaine + fentanyl + propofol + rocuronium in bladder cancer (2 arms), sponsored by Islamic Azad University. Primary endpoint: Patient satisfaction with surgery results. Started Nov 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20241007063280N1.